Economic burden of radical cystectomy and trimodal therapy for bladder cancer in the United States: Real-world study.

被引：0
|
作者：
Williams, Stephen B. [1 ]
Yapici, Halit O. [2 ]
Singhal, Puneet K. [3 ]
Weimer, Ian [2 ]
Pathan, Farah [2 ]
Lodaya, Kunal [2 ]
Li, Haojie [3 ]
机构：
[1] Univ Texas Med Branch Galveston, Galveston, TX USA
[2] Boston Strateg Partners Inc, Boston, MA USA
[3] Merck & Co Inc, Rahway, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
127-961; 261-566-148-2649; 283-183-138-226; 130-273-11258; 130-273-11555; 4; 3; 2;
D O I：
10.1200/JCO.2024.42.4_suppl.555
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：555 / 555
页数：1
相关论文
共 50 条
  • [41] Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United States
    Lin-Brande, Michael
    Nazemi, Azadeh
    Pearce, Shane M.
    Thompson, Eli R.
    Ashrafi, Akbar N.
    Djaladat, Hooman
    Schuckman, Anne
    Daneshmand, Siamak
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (03) : 180.e1 - 180.e9
  • [42] CLINICAL AND ECONOMIC BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN VETERAN PATIENTS IN THE UNITED STATES: A REAL-WORLD EVALUATION
    Wang, L.
    Huang, A.
    Baser, O.
    VALUE IN HEALTH, 2013, 16 (03) : A233 - A233
  • [43] Real-world survival and economic burden among patients with locally advanced or metastatic urothelial carcinoma in the United States
    Chen, Ronald C.
    Fuldeore, Rupali
    Greatsinger, Alexandra
    Hepp, Zsolt
    Liu, Qing
    Wright, Phoebe
    Xie, Bin
    Yang, Hongbo
    Young, Christopher
    Zhang, Adina
    Mucha, Lisa
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03) : 189e9 - 189e18
  • [44] The use of real-world evidence in economic assessments of pharmaceuticals in the United States
    Lee, Woojung
    Dayer, Victoria
    Jiao, Boshen
    Carlson, Josh
    Devine, Beth
    Veenstra, David
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 306 - 306
  • [45] Use of real-world evidence in economic assessments of pharmaceuticals in the United States
    Lee, Woojung
    Dayer, Victoria
    Jiao, Boshen
    Carlson, Josh J.
    Devine, Beth
    Veenstra, David L.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (01): : 5 - 14
  • [46] Patterns and predictors of treatment in muscle-invasive bladder cancer (MIBC): A real-world study.
    Lu, Zengqi
    Clement, Jessica M.
    Pan, Qi
    Swede, Helen
    Mehta, Rajni
    Wang, Xiaoyan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Re: Propensity Score Analysis of Radical Cystectomy Versus Bladder-sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
    El-Achkar, Adnan
    Kassouf, Wassim
    EUROPEAN UROLOGY, 2018, 73 (05) : 810 - 811
  • [48] Re: Real-World Patterns of Care for the Overactive Bladder Syndrome in the United States
    Penson, David F.
    JOURNAL OF UROLOGY, 2016, 196 (03): : 848 - 848
  • [49] Comparative cost-effectiveness of trimodal therapy and radical cystectomy for management of muscle-invasive bladder cancer.
    Joyce, Daniel D.
    Wymer, Kevin
    Boorjian, Stephen A.
    Gore, John L.
    Khaki, Ali Raza
    Raldow, Ann Caroline
    Williams, Stephen B.
    Smith, Angela B.
    Sharma, Vidit
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 572 - 572
  • [50] Re: Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2021, 205 (03): : 929 - 930
12345